FDA Inspection
Erode Cancer CentreErode Cancer Centre – FDA Inspection, Nov 21, 2023
Record Details
This FDA Inspection record concerns Erode Cancer Centre, with an inspection on November 21, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 286c4388-daec-4f68-a188-fa7cde16104d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1231825
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Erode Cancer Centre
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 24, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Erode Cancer Centre
- FDA Inspection 1121547 - 2020-02-28
- FDA Inspection 1004974 - 2017-02-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.